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The Journal of Immunology
Molecular and Cellular Mechanisms of Mycobacterium
avium-Induced Thymic Atrophy
Margarida Borges,*,†,1 Palmira Barreira-Silva,‡,x,1 Manuela Flo´rido,*,2 Michael B. Jordan,{,‖
Margarida Correia-Neves,‡ and Rui Appelberg*
Thymic atrophy has been described as a consequence of infection by several pathogens and shown to be induced through diverse
mechanisms. Using the mouse model of Mycobacterium avium infection, we show in this study that the production of NO from
IFN-g–activated macrophages plays a major role in mycobacterial infection-induced thymic atrophy. Our results show that
disseminated infection with a highly virulent strain of M. avium, but not with a low-virulence strain, led to a progressive thymic
atrophy. Thymic involution was prevented in genetically manipulated mice unable to produce IFN-g or the inducible NO synthase.
In addition, mice with a selective impairment of IFN-g signaling in macrophages were similarly protected from infection-induced
thymic atrophy. A slight increase in the concentration of corticosterone was found in mice infected with the highly virulent strain,
and thymocytes presented an increased susceptibility to dexamethasone-induced death during disseminated infection. The ad-
ministration of an antagonist of glucocorticoid receptors partially reverted the infection-induced thymic atrophy. We observed
a reduction in all thymocyte populations analyzed, including the earliest thymic precursors, suggesting a defect during thymic
colonization by T cell precursors and/or during the differentiation of these cells in the bone marrow in addition to local demise
of thymic cells. Our data suggest a complex picture underlying thymic atrophy during infection byM. avium with the participation
of locally produced NO, endogenous corticosteroid activity, and reduced bone marrow seeding. The Journal of Immunology,
2012, 189: 3600–3608.
S
everal microorganisms have been shown to cause premature
thymic involution (1). How much premature thymic dys-
function impacts on the immune system depends on factors
like the age of the individual, the precise mechanisms that caused
thymic atrophy, the consequent ability for thymic recovery after
the resolution of the infection, and the concomitant existence or
not of peripheral lymphocyte depletion (2). When thymic atrophy
occurs in parallel with peripheral lymphopenia, the reconstitution
of the immune system depends to a great extent on the ability of
the thymus to recover its ability to generate new T cells as it has
been extensively shown for AIDS patients (3–5). Because several
mechanisms have been implicated in infection-induced thymic
atrophy and their role varies depending on the microorganism
causing infection, determination of which pathways are respon-
sible for thymic atrophy in distinct situations is essential to define
strategies to prevent thymic atrophy and/or promote the recovery
of thymic function once the infection is controlled.
Even though the thymus undergoes physiologic atrophy with
age, T cells are generated and incorporated into the peripheral
T cell pool in adulthood, albeit at slower rate than in children (6–9).
Thymectomy or thymic dysfunction in early life has been shown
to cause premature aging of the immune system in humans (10),
as well as enhanced autoimmunity in mice (11). Moreover, loss of
thymic activity in adults has been shown to reduce oral tolerance
(12) and to hamper the affinity maturation of Abs (13). Loss of
thymic T cell output in adults has more obvious consequences
when peripheral lymphopenia occurs concomitantly as it is the
case in AIDS patients (14).
Several mechanisms have been implicated in infection-induced
thymic atrophy. A major role was attributed to corticosteroids be-
cause of their ability to cause thymocyte death (15–18). The in-
creased production of the proinflammatory cytokines TNF (16)
and IFN-a (19) has also been proposed. Although this increased
apoptosis of the thymocytes is one of the mechanisms leading to
thymic atrophy, the increased export of immature T cells (20) and
the disturbance of thymic epithelia (19) have also been suggested.
We have previously shown that infection of C57BL/6 mice with
a highly virulent strain of Mycobacterium avium (strain ATCC
25291 SmT) induces profound peripheral T cell depletion and
premature thymic atrophy (21, 22) and that M. avium is able to
progressively infect the thymus (23, 24). Because IFN-g is a key
molecule in peripheral lymphocyte loss, we aimed at analyzing
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the role of this cytokine in mycobacterial infection-induced thy-
mic atrophy. Moreover, IFN-g is known to cause the upregulation
of the inducible NO synthase (iNOS) in mycobacterial infection
(25), and NO has been shown to synergize with corticosterone in
the induction of apoptosis of thymocytes in in vitro experiments
(26). Thus, we also aimed at determining if NO was leading to
thymic atrophy during mycobacterial infection. IFN-g–induced
macrophage activation and the resulting increase in iNOS activity
were identified as a major mechanism responsible for M. avium-
induced thymic involution. Moreover, we show that IFN-g–induced
thymic atrophy synergized with corticosterone signaling. Notably,
infection with a low-virulence strain that also leads to iNOS up-
regulation through IFN-g activation did not lead to thymic atrophy
suggesting that corticosterone upregulation is essential for infection-
induced thymic atrophy. Finally, we provide evidence that the
earliest steps of T cell differentiation might also be compromised.
Materials and Methods
Mice, infection, and thymectomy
C57BL/6 wild-type (WT) mice were purchased from Charles River Lab-
oratories (Barcelona, Spain). IFN-g–deficient C57BL/6 (IFN-g KO) mice
were bred in our facilities from a breeding pair purchased from The
Jackson Laboratory (Bar Harbor, ME). Transgenic mice with a selective
impairment in IFN-g signaling in macrophages (MIIG) (27) were bred at
the Institute for Molecular and Cell Biology (University of Porto, Porto,
Portugal) from a breeding pair provided by the Cincinnati Children’s
Hospital Medical Center and the University of Cincinnati College of
Medicine (Cincinnati, OH). iNOS-deficient C57BL/6 mice (iNOS KO) (28)
were bred in our facilities after back-crossing the original strain (kindly pro-
vided by Drs. J. Mudgett, J.D. MacMicking, and C. Nathan, Cornell Uni-
versity, New York, NY) onto a C57BL/6 background for seven generations.
Eight- to ten-week-old female mice were infected i.v. with 106 CFU
of the highly virulent M. avium strain ATCC 25291 SmT (obtained from
the American Type Culture Collection, Manassas, VA) or the low-virulence
strain 2447 (provided by Dr. F. Portaels, Institute of Tropical Medicine,
Antwerp, Belgium) through a lateral tail vein. Bacterial inocula were pre-
pared as described previously (21). The bacterial load in the organs was
determined as previously described (23). Although no signs of distress
were observed for the first 2 mo upon infection, some animals showed
signs of deterioration of body condition in a non-synchronous way. To
avoid excessive and unnecessary suffering of animals, humane endpoints
were applied. Mice were sacrificed when reaching 25% weight loss.
Thymectomy or sham thymectomy surgical procedures were performed
on anesthetized 8-wk-old mice 2 wk prior to infection. The thymi were
removed by aspiration through a supra-sternum incision.
All animal experiments were performed in accordance with the rec-
ommendations of the European Convention for the Protection of Vertebrate
Animals Used for Experimental and Other Scientific Purposes (ETS 123)
and 86/609/EEC Directive and Portuguese rules (DL 129/92). The animal
experimental protocol was approved by the competent national authority
Direcc¸a˜o Geral de Veterina´ria.
Cell preparation
Spleens and thymi were collected and processed individually. Cell suspen-
sions were obtained by gentle mechanical dissociation in PBS containing 3%
FCS. RBCs were lysed using a hemolytic solution (155 mM NH4Cl, 10 mM
KHCO3, pH 7.2) for 4 min at room temperature, and cells were resuspended
in DMEM supplemented with 10% heat-inactivated FCS, 10 mM HEPES,
1 mM sodium pyruvate, 2 mM L-glutamine, 50 mg/ml streptomycin, and
50 U/ml penicillin (all from Invitrogen Life Technologies). The number of
viable cells was counted by trypan blue exclusion using a hemocytometer.
Histology
Thymi were fixed on paraformaldehyde (4% in PBS) and embedded in
paraffin. Thymic sections (2–3 mm) were stained by the Ziehl–Neelsen
technique. Slides were visualized using an epifluorescence microscope
(BX61 microscope) and photographed with an Olympus DP70 camera.
Flow cytometry
For the flow cytometry analysis of splenocytes, 106 cells were stained with
FITC-conjugated anti-CD4 (RM4-5) or anti-CD19 (6D5) and PE-conjugated
anti-CD8 (53-6.7). Propidium iodide (Sigma-Aldrich) was added at a final
concentration of 1 mg/ml to allow the exclusion of dead cells. For thy-
mocyte analysis, 106 thymic cells were labeled with distinct combinations
of the following Abs: FITC or allophycocyanin-conjugated anti-CD3
(145-2C11), PE–Cy5.5 or V450-conjugated anti-CD4 (RM4-5), PE or
V500-conjugated anti-CD8 (53-6.7), PerCP–Cy5.5–conjugated anti-CD24
(M1/69), allophycocyanin–Cy7–conjugated anti-CD25 (PC61), PE–Cy7–
conjugated anti-CD44 (IM7), and PE-conjugated anti–c-Kit (2B8). For Lin,
the following Abs were used conjugated with the same fluorochrome (FITC):
anti-CD19 (6D5), anti-B220 (RA3-6B2), anti-CD11b (M1/70), anti-CD11c
(N418), anti-NK1.1 (PK136), anti-Gr1 (RB6-8C5), anti-TER119 (TER119).
All Abs were purchased from BioLegend (San Diego, CA) except the V450-
conjugated anti-CD4 (RM4-5) and the V500-conjugated anti-CD8 (53-6.7),
which were obtained from BD Biosciences. The acquisition of the spleen
or thymus cell populations was performed on a FACSCalibur flow cytometer
using CellQuest software (BD Biosciences), on an LSRII, or on a FACS-
Canto II flow cytometer using BD FACSDiva software (BD Biosciences).
Data were analyzed using FlowJo software (Tree Star, Ashland, OR).
Blockage of glucocorticoid receptors
Mifepristone (RU486; Sigma-Aldrich), a synthetic glucocorticoid receptor
antagonist, was dissolved in sterile polyethylene glycol 400 (Sigma-Aldrich)
at a concentration of 5 mg/ml. Treatment was initiated by daily s.c. injections
of either RU486 (25 mg/kg; 0.1 ml volume) or an equivalent volume of
polyethylene glycol 400 (vehicle-treated mice) 1 d prior to infection until
day 12 postinfection. This dose was previously shown to be effective in
the reversion of corticosterone-dependent lymph node atrophy in stressed
and influenza-infected mice (29, 30). From days 13 to 74 postinfection,
mice were treated daily by i.p. injection with either RU486 (2.5 mg/kg;
0.2 ml volume) or an equivalent volume of vehicle. The RU486 solution
for i.p. injections was obtained by dissolving RU486 in DMSO (Sigma-
Aldrich) at a concentration of 50 mg/ml. This DMSO stock solution was
diluted 1/10 with 1 M acetic acid just prior to use and then diluted again
in PBS/BSA to a final concentration of 250 mg/ml.
Determination of serum corticosterone level
To obtain the serum concentration of corticosterone at basal levels, blood
samples were obtained at 9 AM from a venous incision at the tip of the tail
during a period not exceeding 2 min for each mouse, to avoid corticosterone
sera level increase due to handling. Sera were collected and stored at280˚C
until assayed for corticosterone by RIA using a 125I RIA Kit (MP Bio-
medicals). Corticosterone levels were determined from a standard curve
and expressed in nanograms per milliliter.
Dexamethasone sensitivity test
Control or infected mice were treated i.p. with dexamethasone (Oradexon;
Organon, Oss, The Netherlands) at 0.1, 1.0, and 4.0 mg/kg or PBS (PBS-
treated animals) 24 h before sacrifice. Mice were sacrificed at day 50 post-
infection, and organs were removed for analysis. Thymocyte suspensions
were obtained and analyzed by flow cytometry as described earlier.
Statistical analysis
Results were expressed as mean + SD. Statistical significance was calcu-
lated by using the two-tailed Student t test for data presented on Fig. 2A
and the one-way ANOVA on all the other figures. The p values,0.05 were
considered statistically significant.
Results
Severe thymic atrophy occurs in mice infected with the highly
virulent M. avium strain but not in mice infected with the
low-virulence M. avium strain
We compared the fate of the thymus in WT mice intravenously
infected with a low-virulence strain of M. avium (strain 2447)
and that of the thymus in mice infected with the highly virulent
strain of M. avium (strain 25291). As shown in Fig. 1A–C, the size,
weight, and cellularity of thymi from mice infected with M. avium
2447 did not differ from those of thymi of noninfected animals up
to 80 days postinfection (dpi). Infection with strain 25291 led
to a progressive shrinking of the organ, accompanied by a drastic
reduction of its weight and cellularity. Flow cytometry analysis of
the major thymocyte populations revealed no differences in thymi
of mice infected with the low-virulence strain compared with thymi
from noninfected controls (Fig. 1D–F). Infection with the highly
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virulent strain led to changes in the relative proportions and total
counts of double-negative (DN; CD42CD82), double-positive
(DP; CD4+CD8+), and single-positive (SP; CD4+CD82 or CD42
CD8+) populations. Thymic involution was somehow asynchro-
nous with some mice exhibiting initial signs of thymic dysfunc-
tion sooner than others, as revealed by some variability in the
pattern of thymocyte flow cytometry 60 dpi, illustrated in Fig. 1D.
On average, the cells exhibiting a greater relative depletion were
the DP populations (Fig. 1E) although all populations underwent
massive loss from day 60 up to day 80 postinfection (Fig. 1F).
This thymic atrophy was associated with increased bacterial loads
within the thymus (Fig. 2A) in mice infected with the highly
virulent strain, in agreement with what has been described for
other organs (21, 22). Histologically, increasing numbers of acid-
fast bacilli were detected, and progressive loss of the thymic
structure was observed in samples taken from mice infected with
the highly virulent strain, but no significant alterations were found
in thymi from mice infected with the low-virulence strain up to
80 dpi (Fig. 2B). As previously shown, mice infected with the
highly virulent strain developed peripheral lymphopenia, which
was not observed in the case of infection by strain 2447 (Sup-
plemental Fig. 1A). Removal of the thymus prior to infection
with strain 25291 caused a slight increase in the peripheral de-
pletion of T cells (Supplemental Fig. 1B) suggesting that thymic
atrophy may have minor additive effects on the development of
peripheral lymphopenia.
Thymic atrophy induced by M. avium infection is IFN-g
dependent and mediated by NO
IFN-g is a key cytokine in the protective immune response against
mycobacterial infection (31, 32) but has also been shown to par-
ticipate in the induction of peripheral lymphopenia associated
with M. avium 25291 infection (21, 22). To determine if IFN-g
was also implicated in M. avium infection thymic atrophy, we
analyzed the thymi of IFN-g KO mice during infection by strain
25291. As shown in Fig. 3A, mice that are unable to produce IFN-g
exhibited no thymic atrophy despite having similar mycobacte-
rial burdens (7.9 6 0.5 and 8.0 6 0.4 log10 CFU/thymus in WT
and IFN-g KO mice, respectively, at 70 dpi). This observation
shows that IFN-g is essential for thymic atrophy during M. avium
25291 infection. Although essential for the depletion of lympho-
cytes at the periphery, IFN-g was shown not to act directly on
T cells as the loss of these latter cells occurred in chimeric mice
whose T cells lacked the receptor for IFN-g (22). The most likely
candidate for an IFN-g–responsive effector cell mediating lympho-
cyte or thymocyte loss is the macrophage. Thus, we infected “mac-
rophage insensitive to IFN-g” (MIIG) mice, whose CD68-expressing
cells (mostly macrophages) do not respond to IFN-g (27). In four
FIGURE 1. Infection with the highly
virulent M. avium strain 25291 but not
with the low-virulence strain 2447 in-
duces strong thymus atrophy. (A) Pho-
tographs of thymi from uninfected WT
mice (Ninf) and WT mice infected with
M. avium strains 2447 or 25291 at the
indicated time points. (B and C) Thymus
weight and number of thymocytes from
control noninfected (Ninf) mice and
animals infected with strains 2447 or
25291. (D) Representative plots of anti-
CD4 and anti-CD8 staining of thymi
from control noninfected (Ninf) mice
and mice infected with strains 2447 or
25291. The numbers indicate the per-
centage of cells in each region. (E and F)
Percentage and number of thymic pop-
ulations from control noninfected (Ninf)
mice and animals infected with strains
2447 or 25291. Data represent the mean
of the percentages or the mean and SD
of the numbers of cells. Each group
of noninfected mice comprised three
to four animals, and each group of
infected mice comprised seven animals
analyzed individually. Data presented
represent one experiment of three. *p ,
0.05, **p , 0.01, ***p , 0.001 (sta-
tistically significant differences between
infected and noninfected mice); ###p ,
0.001 (statistically significant differences
between infected groups).
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independent experiments, control WT mice showed consistent thy-
mic atrophy, ranging from 86 to 98% depletion of thymic cells during
infection with strain 25291, whereas MIIG mice showed partial
protection with 66% (p, 0.05), 27% (not statistically significant),
29% (not statistically significant), and 74% (not statistically sig-
nificant) depletion of thymic cells. Fig. 3B shows the data of one of
the experiments where subpopulations were analyzed and where no
statistically significant differences were found. These data show that
the macrophage is one of the cell types mediating thymocyte loss.
One of the major consequences of the activation of macrophages
by IFN-g is the increased production of NO due to the increased
expression of iNOS. To assess the possible role of this reactive
species in the induction of thymic atrophy, we infected iNOS-
deficient animals with strain 25291. As shown in Fig. 3C, iNOS
KO mice did not develop atrophy of the thymus. Notably, the bac-
terial load within the thymus was almost the same between WT and
iNOS-deficient mice (7.7 and 7.5 log10 CFU/thymus in WT and
iNOS KO mice, respectively, at 80 dpi).
Glucocorticoids cooperate with NO in the induction of thymic
atrophy
As increased levels of glucocorticoids (GCs) are widely recognized
as a common cause for increased thymocyte apoptosis during in-
fection (16–18), we questioned whether corticosteroids were nec-
essary for M. avium-induced thymic atrophy. Mice infected with
strain 25291 but not those infected by strain 2447 showed slightly
increased serum levels of corticosterone at 60 and 80 dpi (Fig. 4A).
The increase in corticosterone induced by the highly virulent strain
of M. avium was observed both in control WT mice and in IFN-g–
deficient mice showing that corticosteroids on their own were not
sufficient to induce the atrophy of the thymus. To assess the bio-
logical role of this hormone in thymic atrophy, mice were infected
with strain 25291 and treated daily with a steroid receptor type II
antagonist (RU486) throughout the period of M. avium infection.
In one experiment, the RU486 treatment of infected mice partially
reverted the atrophy of the thymus, whereas in the second experi-
ment, such reversion was complete (Fig. 4B) compared with vehicle-
treated controls. No effect of RU486 on peripheral lymphopenia
was observed in either experiment (data not shown).
Given that corticosterone blood levels showed only minor in-
creases between M. avium 25291-infected and control noninfected
mice and that, in contrast, RU486 treatment was quite active in
FIGURE 2. Infection with M. avium strain 25291 leads to higher bac-
terial loads in the thymus compared with infection with strain 2447. (A)
Representative kinetics ofM. avium infection of the thymus fromWT mice
inoculated with strains 2447 or 25291. Data represent the mean and SD of
CFU from five mice per group from one of three experiments. *p , 0.05,
**p , 0.01, ***p , 0.001 (statistically significant differences between
mice infected with strains 2447 and 25291). (B) Representative thymic
sections from noninfected mice (Ninf) and mice infected with strains 2447
or 25291 stained for acid-fast bacteria (Ziehl–Neelsen method). Scale
bars represent 200 mm in the low-power views and 20 mm in the high-
magnification images. Arrowheads indicate acid-fast bacteria in cases of
low infection burden.
FIGURE 3. Thymus atrophy depends on IFN-g production, IFN-g–
dependent macrophage activation, and NO production. (A) Number of
cells of the thymic populations from WT or IFN-g KO mice, either non-
infected or infected with M. avium 25291 at 75 dpi. (B) Number of cells of
the thymic populations from WT or MIIG transgenic mice, either nonin-
fected or infected with M. avium 25291 at 80 dpi. (C) Number of cells of
the thymic populations from WT or iNOS KO mice, either noninfected or
infected withM. avium 25291 at 80 dpi. Data represent the mean and SD of
the numbers of cells. Each group of mice comprised three to seven animals
analyzed individually. Data shown represent one of three experiments. **p,
0.01, ***p , 0.001 (statistically significant differences between infected
and noninfected mice); #p , 0.05, ##p , 0.01, ###p , 0.001 (statistically
significant differences between infected groups). Ninf, Noninfected.
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preventing thymic atrophy in infected animals, we next investi-
gated if thymocytes became more sensitive to apoptosis-inducing
stimuli during infection by the highly virulent strain of M. avium.
To that purpose, control and infected mice were administered
dexamethasone, known to induce extensive cell death via corti-
costeroid receptor activation (33). Because IFN-g KO mice do not
exhibit thymic atrophy, we compared the effects of dexamethasone
in both IFN-g KO and WT animals. Mice were given increasing
doses of dexamethasone (0.1, 1.0, and 4.0 mg/kg) 24 h before
sacrifice at 50 dpi and compared with noninfected controls treated
in a similar way. We observed a dose-dependent decrease of total
and DP cells in both infected and noninfected WT and IFN-g KO
mice (Fig. 4C, 4D). Thymocyte loss was exacerbated by infection
in WT mice but not in IFN-g KO animals showing that IFN-g
production during infection increases thymocyte susceptibility to
dexamethasone-induced cell death.
Impairment of the earliest stages of thymocyte development
To investigate further at what levels of thymocyte development the
infection affects cell viability, we analyzed in detail DN thymo-
cytes of mice infected with each M. avium strain. Whereas in mice
infected with the low-virulence strain no differences were observed
in the DN1–DN4 populations, animals infected with M. avium
25291 showed progressive reduction in cell numbers at all stages
(Fig. 5A, 5B). The relative reduction in all stages was similar such
that the proportions remained almost unchanged (Fig. 5A). We next
analyzed what changes were found in M. avium 25291-infected
mice that showed no thymic atrophy either because they were unable
to produce IFN-g, their macrophages did not respond to IFN-g, or
they do not express iNOS. No major alterations were induced by
infection in IFN-g KO or MIIG mice that exhibited normal or
only slightly reduced numbers of DN1–DN4 subpopulations (Fig.
5C, 5D). Likewise, iNOS-deficient mice also maintained most of
these subpopulations unchanged during infection except for DN2
(Fig. 5E). Finally, we analyzed the most immature thymocytes,
the early thymic precursors (ETP), defined in the DN population as
lineage-negative, CD44+, CD252, and c-Kit+ cells (see Supplemental
Fig. 2 for a schematic representation of the gating strategy used to
select this population). These cells were almost lost during infection
of WT mice with the highly virulent strain of M. avium but not
during infection with the strain 2447 (Fig. 6A, 6B). No loss was
found in IFN-g KO or MIIG mice infected with the highly virulent
strain 25291 (Fig. 6C–F), but a statistically significant reduction
was found in iNOS KO animals (Fig. 6G, 6H).
Discussion
In this study, we examined the mechanisms underlying the emer-
gence of progressive thymic atrophy in mice infected with M. avium
25291. We showed that IFN-g–deficient animals are resistant to
the M. avium-induced thymic atrophy consistent with the fact
that albeit essential for protective immunity against mycobacteria
(31, 32), production of IFN-g by T cells may not always be cor-
related with protection during infection by HIVor Mycobacterium
tuberculosis (34–37). IFN-g has been shown to be involved in
the development of peripheral lymphopenia in mice infected with
M. avium 25291 (22), to limit the exacerbated T cell activation
responsible for immune pathology associated with granulomatous
lesions (38), and to increase apoptosis of DP thymocytes (39). Fur-
thermore, IFN-g produced during measles virus infection not only
inhibited cell proliferation but also disrupted the thymic epithelium
responsible for thymocyte survival and differentiation into mature
T cells, leading to thymic atrophy (40). Because IFN-g does not
act directly on lymphocytes in the periphery to induce their de-
mise (22), and macrophages accumulate in large numbers in tissue
granulomas and in the thymus of M. avium-infected mice (23, 24),
we assessed the involvement of these phagocytes in the IFN-g–
mediated atrophy of the thymus. MIIG mice have macrophages
(defined as CD68-expressing cells) that do not respond to IFN-g
and were found in this study not to develop thymic atrophy. This
shows that macrophages respond to IFN-g and mediate to a great
extent the involution of the organ. Because IFN-g–activated mac-
rophages secrete important quantities of NO, we next evaluated
the fate of the thymus in iNOS-deficient animals infected with
strain 25291. These mice showed no evidence of thymic atrophy.
FIGURE 4. GCs are involved in the induc-
tion of thymus atrophy during infection with
M. avium strain 25291. (A) Representative ki-
netics of serum corticosterone levels in WT mice
infected withM. avium 25291 or 2447 compared
with noninfected mice or of IFN-g KO mice
infected with strain 25291 versus noninfected.
(B) Number of thymocytes from noninfected
mice and mice infected for 75 d with M. avium
25291 and treated with either vehicle or RU486
(RU). Data represent the mean and SD of values
obtained from six to eight mice in each group
analyzed individually and represent two inde-
pendent experiments. *p , 0.05, **p , 0.01,
***p , 0.001 (statistically significant differ-
ences between infected and noninfected mice).
(C and D) Decrease of total (C) and DP (D)
thymocytes after dexamethasone treatment of
noninfected or M. avium 25291-infected ani-
mals of either WT or IFN-g KO strains. Data
represent the ratio between the cell numbers
in dexamethasone-treated animals and the cell
numbers in PBS-treated animals (i.e., the frac-
tion of cells remaining after dexamethasone
treatment). Ninf, Noninfected.
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Thus, a major pathway leading to thymic atrophy is dependent on
the induction of iNOS expression in macrophages by IFN-g pro-
duced in response to infection. NO has already been shown to be
important in limiting T cell activity and survival at the periphery
during mycobacterial infections (38), but this is the first dem-
onstration, to our knowledge, of its activity in the thymus of an
infected animal.
The mycobacterial loads in the thymus of mice infected with
strain 25291 were significantly higher than those of mice infected
with strain 2447 raising the possibility that the mycobacteria might
themselves be toxic for the thymic tissue. However, this is not
supported by the fact that the bacterial loads in the thymi of in-
fected WT mice, which undergo atrophy, were very similar to those
found in IFN-g–deficient or iNOS-deficient animals, which did
not develop such atrophy. Moreover, M. avium is known to be
relatively nontoxic as evidenced by the very high microbial burdens
that can be observed in infected hosts and that are still compatible
with their survival (41–43).
The most frequent mechanism implicated in infection-induced
thymic atrophy is increased thymocyte apoptosis due to increased
production of GCs (15–17, 44–46). For example, the severe thymic
atrophy found in mice infected with Trypanosoma cruzi is caused
by an increased production of GCs (17, 47). This can also be seen
during M. tuberculosis infection (48) or in mice given an injection
of M. tuberculosis cord factor (trehalose 6,69-dimycolate) (49). The
activity of GCs might also synergize with that of IFN-g. IFN-g
is known to increase serum levels of TNF, which in turn induces
thymocyte apoptosis and augments the susceptibility of thymocytes
to GCs (50). Given the importance of GCs in thymic involution,
we studied whether GCs were implicated in the depletion of thy-
mocytes during M. avium infection. Indeed, the infection with the
highly virulent strain led to an increase, albeit small, of serum cor-
ticosterone levels. To determine if this increase affected thymocyte
numbers, we performed an in vivo functional assay using an an-
tagonist of the GC receptor (RU486). In two independent experi-
ments, RU486 partially or completely reversed M. avium-induced
thymic atrophy. Furthermore, infection increased thymocyte de-
pletion by dexamethasone with cells from WT animals being more
susceptible than those of IFN-g–deficient mice. These data show
an increase in susceptibility to GC-mediated thymocyte elimina-
tion. Although it is unclear to what extent GCs are required for
M. avium-induced thymic atrophy, we suggest that they do play
at least a partial role. It is clear, however, that GCs on their own
are not sufficient to induce M. avium-induced thymic atrophy and
that they need to synergize with IFN-g or IFN-g–induced path-
ways. The source of the GCs that participate in thymic involution
is unclear. It has been shown that the murine thymus itself is
capable of producing GCs (51, 52), and it was suggested that thy-
mic epithelial cells may be able to produce GCs that would act
directly in thymocytes (53, 54). The mechanisms that underlie
the IFN-g dependence to GC sensitivity are also not known, al-
though changes in the levels of Notch and Bcl-2 expression have
been suggested (55). Further work is needed to clarify this issue.
Because thymocytes expand several orders of magnitude from
incoming bone marrow-derived precursors, a reduction in early
FIGURE 5. Infection with M. avium strain 25291 induces depletion of
all subpopulations of DN thymocytes, which depends on IFN-g produc-
tion, IFN-g–dependent macrophage activation, and NO production. (A and
B) Percentage and number of DN thymic subpopulations from noninfected
mice and mice infected with strains 2447 or 25291. (C) Number of DN
thymic subpopulations fromWTand IFN-g KO mice, either noninfected or
infected with M. avium 25291 at 80 dpi. (D) Number of DN thymic sub-
populations from WT and MIIG mice, either noninfected or infected with
M. avium 25291 at 80 dpi. (E) Number of DN thymic subpopulations from
WT and iNOS KO mice, either noninfected or infected with M. avium 25291
at 80 dpi. Data represent the mean and SD of the number of cells. Each
group of mice comprised three to six animals analyzed individually. Data
shown represent one experiment of three. *p , 0.05, **p , 0.01, ***p ,
0.001 (statistically significant differences between infected and control mice);
#p , 0.05, ##p , 0.01, ###p , 0.001 (statistically significant differences
between infected groups). Ninf, Noninfected.
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thymic precursors could affect thymic cellularity. The progressive
reduction in thymocyte numbers observed in this study was seen
among the DN1 to the DN4 stages to an extent that was propor-
tional to the relative abundance of these cells in a normal thymus.
Furthermore, the most immature thymocytes (c-Kit+, lin2 DN1
cells) were found to be severely deficient in advanced stages of
thymic atrophy. These observations are consistent with several
scenarios of thymocyte depletion: 1) it might occur predominantly
in the thymus and affect all cell types, 2) there might be a pre-
dominant effect on the recently arrived precursors affecting the
subsequent ability to expand inside the thymic tissue, or 3) a re-
duction in the release of precursors from the bone marrow might
reduce thymus seeding. In this context, it has been shown that
early lymphoid progenitors in mouse and man are highly sensitive
to GCs (56), and alterations in chemokine expression and bone
marrow retention phenomena are observed in HIV-infected pa-
tients (57). Our data with iNOS-deficient mice suggest that at least
some of the reduction in thymocyte numbers is occurring locally
in the thymus. iNOS-deficient mice showed a statistically significant
reduction in the number of early thymocyte precursors suggesting
that NO-independent mechanisms lead to the failure of the bone
marrow to seed the thymus. Yet, despite the reduced seeding of
the thymus by early thymocyte precursors, iNOS-deficient animals
did not develop thymic atrophy indicating that NO may be required
for local thymocyte death in the thymic tissue. The lower production
of thymic precursors by the bone marrow might be due to the
direct action of IFN-g on hematopoietic stem cells or multipotent
progenitors as has already been proposed (58–60). The fact that
MIIG mice are not as well protected from thymocyte loss as
IFN-g–deficient mice suggests that IFN-g may also act on cells
other than the macrophage, namely the progenitor cells in the bone
marrow. Although thymic emigrants are important for the main-
tenance of the peripheral lymphocyte pool (61–63) and the loss of
thymic output may accelerate the loss of splenic T cells, as shown
in this study in thymectomized mice (Supplemental Fig. 1B), we
found that peripheral lymphopenia still occurs in situations where
the thymus remains apparently intact such as in iNOS-deficient
animals or when GC activity has been blocked by the receptor
antagonist RU486 (data not shown).
In summary, the current report identifies the role of IFN-g–
activated macrophages and their ability to produce NO in the de-
velopment of thymic atrophy most likely coadjuvanted by the in-
creased susceptibility to GC-mediated thymocyte apoptosis that
develops during infection with the highly virulent strain of M. avium
FIGURE 6. Infection with M. avium 25291 induces
depletion of the early thymocyte precursors and depends
on IFN-g production, IFN-g–dependent macrophage
activation, and NO production. (A and B) Percentage
(A) and number (B) of ETP from noninfected thymi
and from thymi of WT mice infected with M. avium
strains 2447 or 25291. (C and D) Percentage (C) and
number (D) of ETP from noninfected thymi and from
thymi of WTor IFN-g KO mice infected withM. avium
25291 at 80 dpi. (E and F) Percentage (E) and number
(F) of ETP from noninfected thymi and from thymi of
WT or MIIG mice infected with M. avium 25291 at
80 dpi. (G and H) Percentage (G) and number (H) of
ETP from noninfected thymi and from thymi of WT
or iNOS KO mice infected with M. avium 25291 at
80 dpi. Data represent the mean of the percentages or
the mean and SD of the number of cells. Each group
of mice comprised three to six animals analyzed in-
dividually. Data shown represent one experiment of
three. *p , 0.05, **p , 0.01, ***p , 0.001 (statis-
tically significant differences between infected and
noninfected control mice); #p , 0.05, ##p , 0.01,
###p , 0.001 (statistically significant differences be-
tween infected groups). Ninf, Noninfected.
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and suggests the possibility of a failure of the bone marrow to seed
the thymus with precursors.
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Supplementary figures 
 
Figure S1: Thymectomy slightly increases peripheral lymphopenia induced by infection 
with M. avium 25291.  
A. Cellular composition of the spleens from non-infected (Ninf) mice and C57Bl/6 mice 
infected with M. avium 2447 or 25291 at 75 dpi. Data presented represent the mean and 
standard deviation of the number of cells and represents one experiment out of two with 
six mice analyzed individually in each group. Statistically significant differences between 
infected and control mice are labeled *p<0.05, ***p<0.001. Statistically significant 
differences between infected groups are labeled ###p<0.001. B. Cellular composition of 
the spleens of non-infected (Ninf) C57Bl/6 mice or M. avium 25291-infected C57Bl/6 
mice at 90 dpi that either were subjected to sham surgery (SHAM) or were 
thymectomized (TX). Mice were infected i.v. with 106 M. avium 25291 two weeks after 
thymectomy. Data represent the mean and standard deviation of the number of cells and 
represents one experiment out of three with six mice in each group analyzed individually. 
Statistically significant differences between infected and control mice are labeled ***p 
<0.001. Statistically significant differences between non-infected (Ninf) SHAM and TX 
mice are labeled #p<0.05, ## p<0.01. 
 
Figure S2: Schematic representation of the gating used to select thymic populations by 
flow cytometry. 
A. The four main thymic populations were selected on the lymphocyte gate after 
elimination of duplets and lineage markers (lin) positive cells (cells expressing CD19, 
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B220, CD11b, CD11c, NK1.1, Gr1, and/or TER119), and according to the expression of 
CD4 and CD8 molecules: DN (CD4-CD8-), DP (CD4+CD8+); CD4SP (CD4+CD8-) and 
CD8SP (CD4-CD8+). B. The four DN subpopulations were selected on the DN gate as 
not expressing CD3 molecule and according to the expression of CD44 and CD25: DN1 
(CD44+CD25-), DN2 (CD44+CD25+); DN3 (CD44-CD25+) and DN4 (CD44-CD25-). 
Early thymic precursors (ETP) were selected on the DN1 gate as the cells presenting high 
expression of cKit. 
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